- Home
- ALKT vs INVA Comparison
ALKT vs INVA Comparison
Compare ALKT & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALKT | INVA |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALKT | INVA |
|---|---|---|
| Price | $13.41 | $20.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $28.57 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 1.8M | 783.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | $152,159,000.00 | ★ $217,217,000.00 |
| Revenue This Year | $21.85 | $8.95 |
| Revenue Next Year | $16.90 | $12.65 |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | 35.68 | ★ 62.63 |
| 52 Week Low | $13.35 | $16.52 |
| 52 Week High | $24.91 | $25.15 |
Technical Indicators
Market Signals| Indicator | ALKT | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 20.74 | 47.78 |
| Support Level | N/A | $20.44 |
| Resistance Level | $17.81 | $21.73 |
| Average True Range (ATR) | 0.93 | 0.50 |
| MACD | -0.70 | 0.01 |
| Stochastic Oscillator | 0.66 | 51.48 |
Price Performance
Historical ComparisonAbout ALKT Alkami Technology Inc.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.